On-Pump and Off-Pump Coronary Artery Bypass Device Market Size, Share & COVID-19 Impact Analysis | Global | 2021-2027 | MedCore | Includes: ONCAB Disposables Market, Perfusion System Market, Stabilizer Device Market, Positioner Device Market

  • Year: 2021
  • Scope: 10 Years
  • Region: Global
  • Type: MedCore

Product Description

The global on-pump coronary artery bypass device (ONCAB) market is estimated to increase over the forecast period to exceed $604.4 million by 2027. The global off-pump coronary artery bypass device (OPCAB) market is projected to increase over the forecast period to reach $236.2 million by 2027.

LivaNova, Terumo, and Medtronic were the share leaders in the global on-pump coronary artery bypass device market. This global analysis covers over 70 countries and includes ONCAB procedures and is segmented by the ONCAB disposables market and the perfusion system market.

Medtronic, Getinge, and Terumo were the share leaders within the global off-pump coronary artery bypass device market. This global analysis covers over 70 countries and includes OPCAB procedures and is segmented by the stabilizer device market and the positioner device market.


  • Unit Sales, Average Selling Prices, Market Size & Growth Trends
  • ONCAB and OPCAB Procedures
  • COVID-19 Impact Analysis
  • Market Drivers & Limiters
  • Market Forecasts Until 2027, and Historical Data to 2017
  • Recent Mergers & Acquisitions
  • Disease Overviews
  • Company Profiles, Product Portfolios, and SWOT for Top Competitors

On-Pump Coronary Artery Bypass Device Market Insights

The global market for ONCAB devices consists of disposable devices and capital equipment. Disposable ONCAB devices are directly related to the number of ONCAB procedures performed. As ONCAB procedures remain stable, disposable unit sales will also remain stable. Capital equipment sales are also expected to remain relatively stable over the forecast period. The market for perfusion systems includes all heart-lung machines sold. The value of the market is expected to appreciate over the forecast period, due to an increase in units sold.On-Pump coronary artery bypass device global market growth by segment from 2017-2027

Off-Pump Coronary Artery Bypass Device Market Insights

As the global population grows older, the units sold within the OPCAB market will continue to grow. The ASP within the market is relatively stable. However, as technology and innovation continue to progress, there will be a gradual shift towards preferring higher-end devices. The stable OPCAB procedure volume will cause unit sales of the positioner device segment to remain consistent over the forecast period. Innovation and product development will drive an increase in the ASP of positioner devices. One stabilizer device is used in each OPCAB procedure; therefore, the OPCAB procedure volume directly impacts unit sales of the stabilizer device segment over the forecast period.Off-Pump Coronary Artery ByPass Device Global Market Growth


The global on-pump and off-pump coronary artery bypass device markets are controlled by LivaNova, Terumo, Medtronic, and Getinge.Medtronic, Gentinge, Terumo, and LivaNova: Top Competitors in the on/off coronary bypass device market

In 2020, Medtronic was the leading competitor in the OPCAB market. For stabilizers, Medtronic offers its Octopus™ Evolution, Octopus™ 4, and Octopus™ 4.3 tissue stabilizers. The Starfish™ Evo, Starfish™ 2, Urchin™, and Urchin™ 2 complete Medtronic’s heart positioner product portfolio. LivaNova was the leading competitor in 2020 in the ONCAB market. For perfusion systems, LivaNova provides its S5® and C5® heart-lung machines. In addition, LivaNova also provides disposable tubing kits to use in CABG procedures.


Throughout this report, iData Research has covered over 70 countries across the globe in great detail. Each global region may be purchased as a stand-alone report, tailoring the data to your needs. The regions covered are:

  • North America (the United States and Canada)
  • Latin America (Brazil, Mexico, Colombia, Argentina, Peru, Chile, Venezuela, and Other)
  • Western Europe (Germany, France, Italy, Spain, Switzerland, Austria, Portugal, Benelux, Scandinavia, and Other)
  • Central and Eastern Europe (Poland, Turkey, Russia, Greece, Czech Republic, Croatia, Bulgaria, Ukraine, Kazakhstan, Hungary, Romania, Baltic States (Estonia, Latvia, and Lithuania), and Other)
  • Middle East (Saudi Arabia, UAE, Israel, Iran, Kuwait, Qatar, Bahrain, Oman, and Other)
  • Asia Pacific (China, Japan, South Korea, India, Australia, Singapore, Indonesia, Malaysia, Thailand, the Philippines, Brunei, Myanmar, Cambodia, Vietnam, New Zealand, Taiwan, Hong Kong, and Other)
  • Africa South Africa, Egypt, Morocco, Ghana, Nigeria, Libya, Sudan, Uganda, Kenya, and Other)


FREE Sample Report

For a detailed table of contents, please contact an iData Research Product Advisor.
Companies Included:Medtronic,Getinge,Boston Scientific,Abbott,Venus MedTech,Microport,Jiecheng Medical,Cook Medical,Others

iData’s 9-Step Research Methodology

Our reports follow an in-depth 9-step methodology which focuses on the following research systems:

  • Original primary research that consists of the most up-to-date market data
  • Strong foundation of quantitative and qualitative research
  • Focused on the needs and strategic challenges of the industry participants

Step 1: Project Initiation & Team Selection During this preliminary investigation, all staff members involved in the industry discusses the topic in detail.

Step 2: Prepare Data Systems and Perform Secondary Research The first task of the research team is to prepare for the data collection process: Filing systems and relational databases are developed as needed.

Step 3: Preparation for Interviews & Questionnaire Design The core of all iData research reports is primary market research. Interviews with industry insiders represent the single most reliable way to obtain accurate, current data about market conditions, trends, threats and opportunities.

Step 4: Performing Primary Research At this stage, interviews are performed using contacts and information acquired in the secondary research phase.

Step 5: Research Analysis: Establishing Baseline Estimates Following the completion of the primary research phase, the collected information must be synthesized into an accurate view of the market status. The most important question is the current state of the market.

Step 6: Market Forecast and Analysis iData Research uses a proprietary method to combine statistical data and opinions of industry experts to forecast future market values.

Step 7: Identify Strategic Opportunities iData analysts identify in broad terms why some companies are gaining or losing share within a given market segment.

Step 8: Final Review and Market Release An integral part of the iData research methodology is a built-in philosophy of quality control and continuing improvement is integral to the iData philosophy.

Step 9: Customer Feedback and Market Monitoring iData philosophy of continuous improvement requires that reports and consulting projects be monitored after release for customer feedback and market accuracy.

Click Here to Read More About Our Methodology

Explore Options

Report Summary


Select License Type

Off-pump coronary artery bypass (OPCAB), or simply beating-heart coronary artery bypass grafting, uses a median sternotomy to access the heart, similar to on-pump coronary artery bypass (ONCAB) procedures. The important difference is that the cardiopulmonary bypass pump is not employed. Clinical studies show that OPCAB offers several benefits compared to ONCAB procedures, including reductions in bleeding, short-term neurocognitive dysfunction, kidney dysfunction and length of hospital stay.

  • 2021
  • 10 Years
  • Global
  • MedCore
SKU: iDATA_GLCS21_MC_CABG Categories: , ,
    Your Cart
    Your cart is emptyReturn to Report Library